» Articles » PMID: 1662627

Effects of Environmental Factors on the in Vitro Potency of Azithromycin

Overview
Publisher Springer
Date 1991 Oct 1
PMID 1662627
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of media, pH, cations, serum, CO2 or anaerobic atmosphere, inoculum size and time of incubation on the in vitro potency of azithromycin were determined. The potency of azithromycin against all genera was particularly sensitive to changes in pH. The MIC for Staphylococcus aureus strains ranged from 50 micrograms/ml at pH 6 to less than or equal to 0.025 micrograms/ml at pH 8; for erythromycin the MIC change was less (1.6 to 0.05 micrograms/ml). Incubation for 18 h in 5% CO2 or an anaerobic atmosphere (10% CO2, 10% H2, 80% N2) lowered the pH by approximately 0.8 units with gram-negative organisms and 0.4 units with gram-positive organisms. This resulted in an MIC eight times greater than the aerobic MIC. In addition, the MIC100 for azithromycin and erythromycin against Bacteroides strains growing in Wilkins-Chalgren broth fell from 3.1 micrograms/ml in the anaerobic atmosphere to 0.2 and 0.4 micrograms/ml, respectively, when using the Oxyrase enzyme system to remove oxygen. With the Oxyrase system, the pH of the medium at the MIC remained at 7.2, while it fell to 6.7 in the anaerobic gas mixture. An increase in potency for both agents was also observed with other anaerobic species when using the Oxyrase system. The addition of serum produced an increase in potency of azithromycin and erythromycin that correlated with an increase in pH during incubation, despite the use of buffered media. Adding cations to Mueller-Hinton broth resulted in increased MICs for gram-negative organisms; the highest increases observed were four-fold for Escherichia coli.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Campylobacter fetus Adrenal Abscess.

Kerferd J, McLachlan A, Thakkar H, Baumgart S, McKew G Cureus. 2024; 16(11):e73556.

PMID: 39677228 PMC: 11638148. DOI: 10.7759/cureus.73556.


Comparative bactericidal activity of four macrolides alone and combined with rifampicin or doxycycline against at concentrations achievable in foals.

Huguet A, Gourbeyre O, Bernand A, Philibert C, Bousquet-Melou A, Lallemand E Front Pharmacol. 2024; 15:1458496.

PMID: 39624843 PMC: 11608945. DOI: 10.3389/fphar.2024.1458496.


Making Antimicrobial Susceptibility Testing More Physiologically Relevant with Bicarbonate?.

Hinnu M, Putrins M, Kogermann K, Bumann D, Tenson T Antimicrob Agents Chemother. 2022; 66(5):e0241221.

PMID: 35435706 PMC: 9112938. DOI: 10.1128/aac.02412-21.


The antibacterial activity of peptide dendrimers and polymyxin B increases sharply above pH 7.4.

Cai X, Javor S, Gan B, Kohler T, Reymond J Chem Commun (Camb). 2021; 57(46):5654-5657.

PMID: 33972964 PMC: 8186529. DOI: 10.1039/d1cc01838h.


External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.

Selb R, Jansen K, Eckardt M, Tamminga T, Dudareva S, Gassowski M BMC Infect Dis. 2020; 20(1):514.

PMID: 32677988 PMC: 7366306. DOI: 10.1186/s12879-020-05234-w.


References
1.
Fernandes P, Bailer R, Swanson R, Hanson C, McDonald E, Ramer N . In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother. 1986; 30(6):865-73. PMC: 180609. DOI: 10.1128/AAC.30.6.865. View

2.
Foulds G, Chan K, Johnson J, SHEPARD R, Johnson R . Concentrations of azithromycin in human tonsillar tissue. Eur J Clin Microbiol Infect Dis. 1991; 10(10):853-6. DOI: 10.1007/BF01975840. View

3.
Hancock R, Raffle V, Nicas T . Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1981; 19(5):777-85. PMC: 181521. DOI: 10.1128/AAC.19.5.777. View

4.
Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G . Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987; 31(12):1939-47. PMC: 175832. DOI: 10.1128/AAC.31.12.1939. View

5.
Bright G, Nagel A, Bordner J, DESAI K, Dibrino J, Nowakowska J . Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J Antibiot (Tokyo). 1988; 41(8):1029-47. DOI: 10.7164/antibiotics.41.1029. View